Frovatriptan Succinate Tablet, Film Coated
Product Images NDC 69315-157

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Frovatriptan Succinate (NDC 69315-157). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Leading Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cartonlabel (Cartonlabel)

Cartonlabel (Cartonlabel)
Packaging label for Frovatriptan Succinate tablets, film coated, 2.5 mg strength. The label shows the product name, strength in orange boxes, and images of the tablets. It indicates a unit-dose packaging of 9 (1 x 9) tablets, specifies Rx only, and includes storage instructions. The labeler is Leading Pharma, LLC, with manufacturing by LIFELINE PHARMA FZE. The NDC number 69315-157-13 is also visible.*
FDA Label Image

Chemstruct (Chemstruct)

Chemstruct (Chemstruct)
Chemical structure of frovatriptan succinate showing its molecular configuration with labeled functional groups and chemical bonds.*
FDA Label Image

Figure01 (Figure01)

Figure01 (Figure01)
A line graph showing the estimated probability of response over time from the initial dose in hours. It compares placebo (dashed line) to Frovatriptan 2.5 mg (solid line) over a 2-hour period, with the Frovatriptan line indicating a higher probability of response throughout the timeframe.*
FDA Label Image

Figure02 (Figure02)

Figure02 (Figure02)
A line graph showing the estimated probability of remediation or rescue over time from initial dose in hours for Frovatriptan 2.5 mg compared to placebo. The x-axis represents time up to 24 hours, and the y-axis shows probability percentage from 0% to 100%. Two curves compare the outcomes for placebo and Frovatriptan 2.5 mg.*
FDA Label Image

Foildlabel (Foillabel)

Foildlabel (Foillabel)
Blister card containing nine tablets of Frovatriptan Succinate 2.5 mg oral film-coated tablets. Each tablet section displays the proprietary name, strength highlighted in orange, distributor Leading Pharma, LLC, Fairfield, NJ, and a barcode. The label notes Rx only and includes areas for lot number and expiration date.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.